Chikungunya isn't prevalent in the U.S., but travelers are being told to be cautious about getting the vaccine for the ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

Chikungunya is transmitted to humans through the bite of infected female mosquitoes, particularly Aedes aegypti and Aedes ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

An outbreak of a serious infection brought back to the UK by holidaymakers has led to two new vaccines being approved in the ...

FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

Chikungunya, spread by the bites of infected mosquitoes, is a debilitating tropical illness marked by fever and joint pain. About 100 to 200 cases are reported annually among U.S. travelers.

Typical symptoms of chikungunya include fever, severe joint pain, headache, muscle pain and a rash, according to the CDC. "This virus is in a similar category as dengue or Zika and is carried by ...